跳至主要内容
临床试验/NCT02890095
NCT02890095进行中(未招募)不适用

Prospective, Multicenter, Epidemiological Case-control Study, to Establish a Possible Correlation Between Persistent Chemical Contaminants (POPs) and Breast Cancer.

Institut Cancerologie de l'Ouest6 个研究点 分布在 1 个国家目标入组 769 人开始时间: 2016年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
769
试验地点
6
主要终点
correlation between the individual risk of breast cancer and persistent chemical contaminants

研究概览

简要总结

Exposure to certain classes of chemical contaminants, including certain persistent organic pollutants (POPs) with a character of endocrine disruptors, could be one of the factors that lead to increase incidence of breast cancer in the Western world .

However, the causal role of POPs in the onset of breast cancer remains nowadays unproven. Preliminary epidemiological studies on the impact of these environmental factors in breast cancer etiology have ignored the critical periods of exposure. Similarly, they have considered a limited number of pollutants (not including possible joint or synergistic effects between individual compounds) and did not distinguish the different breast cancer subtypes may have different etiologies or even of genetic susceptibility factors (POP polymorphism of detoxification enzymes).

Thus, POPCASE study examines the association between the presence of breast cancer and the levels and exposure profiles to a group of POPs measured in adipose tissue (AT) and blood, in particular using spectrometric methods developed by the team LABERCA (Nantes, France). These internal levels of POPs (organochlorine pesticides, dioxins, PCBs, brominated flame retardants) will be measured both quantitatively (tissue concentrations) and qualitative (relative proportions of different pollutants sought).

详细描述

Exposure to certain classes of chemical contaminants, including certain persistent organic pollutants (POPs) with a character of endocrine disruptors, could be one of the factors that lead to increase incidence of breast cancer in the Western world .

However, the causal role of POPs in the onset of breast cancer remains nowadays unproven. Preliminary epidemiological studies on the impact of these environmental factors in breast cancer etiology have ignored the critical periods of exposure. Similarly, they have considered a limited number of pollutants (not including possible joint or synergistic effects between individual compounds) and did not distinguish the different breast cancer subtypes may have different etiologies or even of genetic susceptibility factors (POP polymorphism of detoxification enzymes).

Finally, this demonstration has not been done for 2 reasons:

  • Multidisciplinary Issues,
  • Need innovative tools for statistical analysis and interpretation of these more integrated environmental data.

Thus, POPCASE study examines the association between the presence of breast cancer and the levels and exposure profiles to a group of POPs measured in adipose tissue (AT) and blood, in particular using spectrometric methods developed by the team LABERCA (Nantes, France). These internal levels of POPs (organochlorine pesticides, dioxins, PCBs, brominated flame retardants) will be measured both quantitatively (tissue concentrations) and qualitative (relative proportions of different pollutants sought).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women ≥ 18 and <75 years
  • According to the arm:
  • Arm A: histologically confirmed diagnosis of invasive breast cancer (only), unilateral or bilateral, outside off recurrence and relapse. Patients who have been supported for a contralateral breast cancer can be included if a period of at least 2-years between the last systemic treatment of inclusion in the study.
  • Arm B: Any woman operated on for breast plastic surgery (breast lift and breast reduction cure only)
  • Performance status (WHO) ≤ 1
  • 5. Patient affiliated to a social security scheme,
  • Patient who signed and dated informed consent form
  • Arm A only: unifocal lesion
  • Arm A only: Clinical stage M0

排除标准

  • Patient with uncontrolled infection
  • Patient pregnant or lactating
  • Patient with a viral infection (HIV, Hepatitis B, Hepatitis C)
  • Patient cannot be regularly monitored for psychological reasons, social, family or geographical.
  • Patient Private of liberty or under a guardianship authority / curatorship.
  • Arm A only: Patient to benefit from neoadjuvant therapy for breast cancer
  • Arm A only Patient with metastatic breast cancer
  • Arm A only Patient diagnosed cancer in situ (intra ductal)
  • Arm A only Patient with BRCA1 or BRCA2 known
  • Arm B only: previous breast plastic surgery, regardless of the type of intervention

研究组 & 干预措施

Arm A = Breast Cancer surgery

Experimental

Arm A : women undergoing breast cancer surgery.

干预措施: Breast cancer surgery (Procedure)

Arm B = Control (plastic surgery)

Other

Arm B : women undergoing breast surgery for the purpose of plastic surgery

干预措施: plastic surgery (Procedure)

结局指标

主要结局

correlation between the individual risk of breast cancer and persistent chemical contaminants

时间窗: 10 years after surgery

The main objective is to establish a correlation between the individual risk of breast cancer and persistent chemical contaminants (POPs) respectively measured in adipose tissue (i.e. storage compartment) and blood (i.e. circulating compartment). =\> Comparison of the assay in the body of a set of chemical pollutants in the environment between the following two groups: * Group A: women receiving breast cancer surgery, * Group B: women receiving breast surgery for the purpose of plastic surgery (control) This contamination profile is "exposure of interest" in this study. The quantification of this exposure is based on a targeted measure, by mass spectrometry, an expanded set of representative substances of the main families of lipophilic POPs (pesticides, PCBs, dioxins and polybrominated compounds) present to trace (femtomol).

次要结局

未报告次要终点

研究者

发起方
Institut Cancerologie de l'Ouest
申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验